Core Viewpoint - Shell plc (SHEL) is expected to report fourth-quarter results on February 5, with earnings estimated at $1.21 per share and revenues of $68.1 billion, reflecting a marginal year-over-year improvement in earnings and a slight increase in revenues [2][4]. Group 1: Previous Quarter Performance - In the third quarter, Shell reported earnings of $1.86 per ADS, exceeding the Zacks Consensus Estimate of $1.72, while revenues of $70.4 billion fell short of expectations by nearly 6% due to declining oil prices [3]. - Shell has beaten earnings estimates in three of the last four quarters, achieving an average earnings surprise of 5.2% [4]. Group 2: Factors Influencing Q4 Results - The marketing division is anticipated to face challenges in Q4, with adjusted earnings under pressure due to seasonal factors, including colder temperatures leading to lower demand for refined fuels and natural gas [6]. - The chemicals sub-segment is expected to report significant losses in adjusted earnings, impacted by volatile raw material costs and changing market demands [7]. - Conversely, Shell's upstream production is projected to increase slightly to between 1.84 million and 1.94 million barrels of oil equivalent per day, aided by the Adura joint venture [8]. Group 3: Earnings Prediction Model - The Zacks model does not predict a definitive earnings beat for Shell, as the Earnings ESP stands at 0.00%, indicating no difference between the Most Accurate Estimate and the Zacks Consensus Estimate [9][11]. - Shell currently holds a Zacks Rank of 4 (Sell), suggesting a cautious outlook for the upcoming earnings report [11].

Core Insights - Oshkosh Corporation (OSK) reported fourth-quarter 2025 adjusted earnings of $2.26 per share, missing the Zacks Consensus Estimate of $2.33 and down from $2.58 in the same quarter last year. However, consolidated net sales increased by 3.5% year over year to $2.69 billion, surpassing the Zacks Consensus Estimate of $2.56 billion [1]. Segment Performance - **Access Segment**: Sales increased by 1.3% year over year to $1.17 billion, driven by higher sales volume in North America, exceeding the Zacks Consensus Estimate of $981 million [2]. - **Vocational Segment**: This segment reported sales of $922.4 million, up 4.7% year over year, attributed to improved pricing, but fell short of the estimate of $1 billion [3]. - **Transport Segment**: Sales reached $566.7 million, a 6.2% increase year over year, benefiting from the ramp-up of the U.S. Postal Service's Next Generation Delivery Vehicle production and higher international sales, beating the estimate of $532 million [5]. Financial Overview - As of December 31, 2025, Oshkosh had cash and cash equivalents of $479.8 million, up from $204.9 million a year earlier. Long-term debt increased to $1.10 billion from $599.5 million [7]. - The company declared a quarterly cash dividend of 57 cents per share, payable on March 3, 2026, to shareholders on record as of February 17, 2026 [7]. 2026 Guidance - Oshkosh expects adjusted earnings per share for 2026 to be approximately $11.50, with full-year net sales projected to be around $11 billion [8]. Zacks Rank & Comparisons - Oshkosh currently holds a Zacks Rank 3 (Hold). In comparison, Ford Motor (F), REV Group (REVG), and PHINIA Inc. (PHIN) are better-ranked stocks in the auto sector, each holding a Zacks Rank 1 (Strong Buy) [9].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Piper Sandler Companies (PIPR) despite higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Piper Sandler is expected to report quarterly earnings of $4.72 per share, reflecting a year-over-year decrease of 1.7%, while revenues are projected to be $515.4 million, an increase of 3.4% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analysts' assessments [4]. Earnings Surprise Prediction - The Zacks Earnings ESP for Piper Sandler is +1.06%, suggesting analysts have recently become more optimistic about the company's earnings prospects [12]. - The stock holds a Zacks Rank of 3, indicating a neutral outlook, but the positive Earnings ESP suggests a likelihood of beating the consensus EPS estimate [12]. Historical Performance - Piper Sandler has consistently beaten consensus EPS estimates in the last four quarters, with a notable surprise of +29.05% in the last reported quarter [13][14]. Industry Context - In the broader financial investment banking sector, Evercore (EVR) is expected to report earnings of $3.83 per share, a year-over-year increase of 12.3%, with revenues projected at $1.06 billion, up 8.3% from the previous year [18]. - Evercore's consensus EPS estimate has been revised up by 2.4% over the last 30 days, with an Earnings ESP of +0.08%, indicating a likelihood of beating the consensus EPS estimate [19].

Core Viewpoint - Analysts expect AbbVie (ABBV) to report quarterly earnings of $2.66 per share, reflecting a year-over-year increase of 23.2%, with revenues projected at $16.36 billion, up 8.3% from the previous year [1] Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions, with empirical research showing a strong correlation between earnings estimate revisions and short-term stock performance [2] Revenue Projections - Analysts estimate 'Net Revenue- Imbruvica' at $714.90 million, indicating a year-over-year decline of 15.7% [4] - 'Net Revenue- Botox Therapeutic- Total' is expected to reach $995.91 million, reflecting a year-over-year increase of 14.1% [4] - 'Net Revenue- Venclexta' is projected at $725.34 million, suggesting a year-over-year increase of 10.7% [4] Neuroscience and Humira Revenue - 'Net Revenue- Neuroscience- Total' is estimated at $3.00 billion, indicating a year-over-year increase of 19.5% [5] - 'Net Revenue- Humira- US' is expected to be $574.85 million, reflecting a significant decline of 53.9% from the prior year [5] - 'Net Revenue- Humira- International' is projected at $374.40 million, indicating a year-over-year decrease of 14.1% [6] Oncology and New Products - 'Net Revenue- Oncology- Elahere- Total' is expected to reach $191.62 million, reflecting a year-over-year increase of 29.5% [6] - 'Net Revenue- Epkinly- International' is projected at $48.50 million, suggesting a substantial year-over-year increase of 120.5% [6] - 'Net Revenue- Qulipta- U.S.' is estimated at $271.58 million, indicating a year-over-year increase of 46% [7] - 'Net Revenue- Qulipta- International' stands at $39.74 million, reflecting a significant year-over-year increase of 165% [8] Stock Performance - AbbVie shares have decreased by 3.5% over the past month, contrasting with the Zacks S&P 500 composite's increase of 0.9%, and the stock is expected to closely follow the overall market with a Zacks Rank 3 (Hold) [8]

Core Insights - DXC Technology, Inc. reported better-than-expected non-GAAP earnings of 96 cents per share for Q3 fiscal 2026, exceeding the Zacks Consensus Estimate by 12.94% and reflecting a 4.3% year-over-year increase [1] - Despite the earnings beat, shares fell 6.3% in after-hours trading due to revenue shortfalls, with reported revenues of $3.19 billion, missing estimates by 0.31% and decreasing 1% year over year [2] Financial Performance - DXC's non-GAAP operating income (Adjusted EBIT) for Q3 was $263 million, down 8% year over year, with a non-GAAP operating margin of 8.2%, a contraction of 70 basis points [5] - The company generated operating cash flow of $414 million and free cash flow of $266 million in Q3, with share repurchases totaling $65 million during the quarter [7] Revenue Breakdown - Revenues from the Consulting & Engineering Services (CES) segment declined 0.1% year over year to $1.27 billion, with an organic decline of 3.6% [4] - Global Infrastructure Services (GIS) revenues totaled $1.61 billion, down 2.7% year over year, with an organic decline of 6.2% [4] - Insurance Services revenues increased 4.6% year over year to $321 million, with organic growth of 3.2% [4] Guidance Update - DXC updated its fiscal 2026 revenue outlook to approximately $12.69 billion, slightly down from the previous guidance of $12.67-$12.81 billion [8] - The adjusted EBIT margin is now projected to be around 7.5%, with adjusted EPS expected to be about $3.15, up from the previous range of $2.85-$3.35 [9] - For Q4, the company anticipates organic revenue declines of 4-5% and adjusted EPS of 65-75 cents [10] Market Position - DXC Technology currently holds a Zacks Rank 2 (Buy), indicating a favorable outlook compared to other stocks in the Computer and Technology sector [12]

Core Viewpoint - Johnson Controls (JCI) is expected to report quarterly earnings of $0.84 per share, a 31.3% increase year-over-year, with revenues projected at $5.66 billion, reflecting a 4.3% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate for the quarter has been revised upward by 0.1% over the past 30 days, indicating analysts have reassessed their projections [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Revenue Projections - Analysts estimate 'Net Sales- Americas' to be $3.73 billion, representing a 35.9% increase from the prior-year quarter [5]. - The forecast for 'Net Sales- EMEA' is $1.27 billion, indicating an 18.1% year-over-year change [5]. - 'Net Sales- APAC' is projected to reach $661.28 million, reflecting a 25.5% increase year-over-year [5]. EBITA Estimates - 'Total Segment Adjusted EBITA- Americas' is expected to be $646.62 million, significantly up from $332.00 million reported in the same quarter last year [6]. - 'Total Segment Adjusted EBITA- APAC' is forecasted at $103.56 million, compared to $49.00 million in the previous year [6]. - Analysts predict 'Total Segment Adjusted EBITA- EMEA' to be $171.31 million, up from $108.00 million reported in the same quarter last year [7]. Stock Performance - Over the past month, Johnson Controls shares have returned +0.4%, while the Zacks S&P 500 composite has changed by +0.9% [7]. - With a Zacks Rank of 3 (Hold), JCI is expected to perform in line with the overall market in the upcoming period [7].

Core Insights - A.O. Smith reported $912.5 million in revenue for Q4 2025, showing no year-over-year change, while EPS increased to $0.90 from $0.85 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate by -1.15%, while the EPS exceeded the consensus estimate by +7.78% [1] Financial Performance - The company’s revenue in North America was $713.7 million, surpassing the average estimate of $708.74 million, reflecting a year-over-year increase of +3.5% [4] - Revenue from the Rest of World segment was $205.7 million, below the estimated $224.71 million, indicating a year-over-year decline of -13.1% [4] - Inter-segment sales reported at -$6.9 million, better than the average estimate of -$11.28 million, but showed a significant year-over-year decrease of -50.7% [4] Stock Performance - A.O. Smith shares have returned +3.9% over the past month, outperforming the Zacks S&P 500 composite, which saw a +0.8% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Viewpoint - Analysts project Emerson Electric (EMR) will report quarterly earnings of $1.41 per share, reflecting a 2.2% year-over-year increase, with revenues expected to reach $4.35 billion, a 4.2% increase from the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 0.1% in the past 30 days, indicating a reassessment by covering analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Net Sales- Intelligent Devices- Total' at $2.96 billion, a 4% increase from the prior-year quarter [5]. - 'Revenue- Software And Control- Control Systems & Software' is projected to be $1.00 billion, reflecting a significant 45.5% increase year-over-year [5]. - The consensus for 'Net Sales- Intelligent Devices- Final Control' is $1.03 billion, indicating a 5.4% increase from the previous year [6]. - 'Net Sales- Intelligent Devices- Measurement & Analytical' is expected to reach $1.01 billion, a 3.6% increase from the prior-year quarter [6]. - 'Net Sales- Intelligent Devices- Safety & Productivity' is projected at $314.19 million, a 0.7% increase year-over-year [7]. - 'Net Sales- Software And Control- Total' is expected to be $1.42 billion, reflecting a 5.1% increase from the previous year [7]. - 'Net Sales- Software and Control- Test & Measurement' is forecasted to reach $417.58 million, a 16.3% year-over-year increase [8]. - 'Net Sales- Intelligent Devices- Discrete Automation' is projected at $602.84 million, indicating a 3.9% increase from the prior year [8]. EBIT Estimates - Analysts expect 'EBIT- Intelligent Devices- Final Control' to reach $244.13 million, compared to $236.00 million in the same quarter last year [8]. - 'EBIT- Intelligent Devices- Measurement & Analytical' is projected at $259.68 million, down from $285.00 million in the previous year [9]. - The average prediction for 'EBIT- Intelligent Devices- Discrete Automation' is $127.41 million, up from $98.00 million year-over-year [9]. - 'EBIT- Software and Control- Total' is expected to be $200.75 million, compared to $195.00 million in the same quarter last year [10]. Stock Performance - Emerson Electric shares have increased by 11.8% over the past month, outperforming the Zacks S&P 500 composite, which rose by 0.8% [11].

Core Viewpoint - Analysts project that Paypal (PYPL) will report quarterly earnings of $1.29 per share, an increase of 8.4% year over year, with revenues expected to reach $8.77 billion, up 4.8% from the same quarter last year [1]. Earnings Projections - The consensus EPS estimate has been revised downward by 2% over the past 30 days, indicating a collective reassessment by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Key Metrics Estimates - Analysts estimate 'Net Revenues- Revenues from other value added services' to be $835.17 million, reflecting a 7.4% increase year over year [5]. - 'Net Revenues- Transaction revenues' are forecasted to reach $7.93 billion, indicating a 4.5% year-over-year change [5]. - 'Total Payment Volume (TPV)' is expected to be $468.32 billion, compared to $437.84 billion reported in the same quarter last year [6]. - The consensus estimate for 'Transaction margin' is 46.3%, down from 47.0% a year ago [6]. - Analysts predict 'Active accounts' will reach 440, up from 434 in the same quarter last year [7]. - The expected 'Number of payment transactions' is 6,607, slightly down from 6,619 reported in the same quarter last year [7]. Market Performance - Shares of Paypal have decreased by 7.4% in the past month, contrasting with a 0.8% increase in the Zacks S&P 500 composite [7]. - With a Zacks Rank of 4 (Sell), PYPL is anticipated to underperform the overall market in the near future [7].

Core Insights - PPG Industries reported a fourth-quarter 2025 profit of $302 million or $1.34 per share, a significant increase from $2 million or a penny per share a year ago, but adjusted earnings per share of $1.51 fell short of the Zacks Consensus Estimate of $1.57 [1][9] - The company's revenues reached $3,914 million, reflecting a 5% year-over-year increase and surpassing the Zacks Consensus Estimate of $3,744.6 million [2][9] Segment Review - The Global Architectural Coatings segment experienced an 8% year-over-year sales increase to $951 million, exceeding estimates due to higher selling prices and favorable foreign currency translation, partially offset by the divestiture of the architectural coatings business in Russia [3] - The Performance Coatings segment saw a 5% year-over-year sales rise to $1,322 million, driven by higher selling prices and favorable currency impacts, despite reduced sales volumes; organic sales grew 3% year over year [4] - The Industrial Coatings segment's sales grew 3% year-over-year to $1,641 million, benefiting from foreign currency translation gains and improved volumes, surpassing estimates [5] Financials - As of the end of the quarter, PPG had $2,163 million in cash and cash equivalents, a 70% increase year over year; long-term debt rose to $6.6 billion, up 35% from the prior-year quarter [6] Outlook - PPG anticipates adjusted earnings per share of $7.70 to $8.10 for full-year 2026, citing ongoing soft global industrial production and mixed regional demand; organic sales are expected to show flat to low single-digit percentage growth [7][9] Price Performance - PPG shares have declined by 11.7% over the past year, contrasting with a 0.4% rise in its industry [8]